Top Markets
#1 Wiki Cat Wiki Cat +27.83%
#2 Ribbita by Virtuals Ribbita by Virtuals +19.03%
#3 Bitway Bitway +18.16%
#4 PulseChain PulseChain +16.92%
#5 Velvet Velvet +16.49%
#6 Cysic Cysic +15.53%
#7 TRIA TRIA +15.19%
#8 Siren Siren +14.04%
#9 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +13.76%
#10 KUB Coin KUB Coin +13.60%
Coin of the day
Wiki Cat Wiki Cat
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.

Inhibitor Therapeutics, Inc.

INTI
Rang in aandelen #30838
Inhibitor Therapeutics, Inc., established in 1992 and based in Tampa, Florida,... Inhibitor Therapeutics, Inc., established in 1992 and based in Tampa, Florida, is a pharmaceutical development enterprise. The company is dedicated to inventing and commercializing medical treatments for patients in the United States who suffer from various cancerous and non-cancerous cell proliferation conditions. A primary focus of their work involves advancing SUBA-Itraconazole, an oral variant of the drug itraconazole, for therapeutic applications in prostate and lung cancers. Furthermore, Inhibitor Therapeutics, Inc. has successfully completed a positive Phase 2b clinical trial for SUBA-Itraconazole in the management of basal cell carcinoma nevus syndrome. The organization was previously known as HedgePath Pharmaceuticals, Inc. until its name was officially changed in August 2019.
Aandeelprijs
$0.089
Laatst gesynchroniseerd: 2026-08-17
Marktkapitalisatie
$15.36M
Verandering (1 dag)
50.59%
Verandering (1 jaar)
111.85%
Land
US
Handel Inhibitor Therapeutics, Inc. (INTI)

Categorie

Healthcare
P/S-ratio voor Inhibitor Therapeutics, Inc. (INTI)
P/S-ratio op 2026 TTM: 0
Volgens de meest recente financiële rapporten en aandelenkoers van Inhibitor Therapeutics, Inc. is de huidige P/S-ratio (TTM) 0. Eind 2026 had het bedrijf een P/S-ratio van 0.
P/S-ratiohistoriek voor Inhibitor Therapeutics, Inc. van 2026 tot 2026
P/S-ratio aan het einde van elk jaar
Jaar P/S-ratio Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
P/S-ratio voor vergelijkbare bedrijven of concurrenten
Bedrijf P/S-ratio Verschil in P/S-ratio Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.74 -
BE